MENU
SYBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Synlogic (SYBX) Ownership - Who owns Synlogic?

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU)... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
301 Binney Street
Phone
+1 617 401-9975
Employees
6
Web
https://www.synlogictx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.99M
P/E Ratio
6.36
Total Cash
15.59M
Projected Growth
N/A
Total Debt
N/A
Revenue
8K
Risk (Beta)
1.53
Dividend Yield
N/A
Total Cash/Share
1.33
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

SYBX
Capitalization
13M
P/E Ratio
6.36
Risk (Beta)
1.53
Dividend Yield
N/A
Total Cash
15.6M
Total Cash/Share
1.33
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
8K
ROE
N/A
Book Value
10.3M
P/B Ratio
1.26
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
2.65
Current Revenue Per Employee
1333.33
Dividends Per Share - Security
N/A
EBITDA
-11.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.30
Shares Held By Institutions
11.4M
Shares Outstanding - Current
11.7M
Total Liabilities
6.23M
Total Volume MTD
N/A
Value
-1
Gain YTD
-21.429
View a ticker or compare two or three
SYBX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Binney Street
Phone
+1 617 401-9975
Employees
6
Web
https://www.synlogictx.com